Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications
Xiaojun Tan, Paul F. Lambert, Alan C. Rapraeger, et al.
Trends in Cell Biology (2016) Vol. 26, Iss. 5, pp. 352-366
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Emerging functions of the EGFR in cancer
Sara Sigismund, Daniele Avanzato, Letizia Lanzetti
Molecular Oncology (2017) Vol. 12, Iss. 1, pp. 3-20
Open Access | Times Cited: 1179
EGFR-mediated autophagy in tumourigenesis and therapeutic resistance
Min Wu, Pinghu Zhang
Cancer Letters (2019) Vol. 469, pp. 207-216
Closed Access | Times Cited: 103
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
Jiaojiao Yu, Dandan Zhou, Xiaoxiao Yang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 84
Extracellular vesicle drug occupancy enables real-time monitoring of targeted cancer therapy
Sijun Pan, Yan Zhang, Auginia Natalia, et al.
Nature Nanotechnology (2021) Vol. 16, Iss. 6, pp. 734-742
Closed Access | Times Cited: 78
A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer
Vetriselvan Subramaniyan, Shivkanya Fuloria, Gaurav Gupta, et al.
Chemico-Biological Interactions (2021) Vol. 351, pp. 109735-109735
Closed Access | Times Cited: 72
The Calcium Binding Protein S100A11 and Its Roles in Diseases
Linqiang Zhang, Tingting Zhu, Huilai Miao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 64
Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications
Mateusz Kciuk, Manzar Alam, Nemat Ali, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5246-5246
Open Access | Times Cited: 40
Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing Both Kinase-Dependent and Kinase-Independent Functions of the Receptor
Yuesheng Zhang
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1218-1232
Open Access | Times Cited: 31
Small-molecule probes from bench to bedside: advancing molecular analysis of drug–target interactions toward precision medicine
Sijun Pan, Aixiang Ding, Yisi Li, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5706-5743
Closed Access | Times Cited: 30
SARS-CoV-2 aberrantly elevates mitochondrial bioenergetics to induce robust virus propagation
Hye Jin Shin, Wooseong Lee, Keun Bon Ku, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Building a translational cancer dependency map for The Cancer Genome Atlas
Xu Shi, Christos Gekas, Daniel Verduzco, et al.
Nature Cancer (2024) Vol. 5, Iss. 8, pp. 1176-1194
Open Access | Times Cited: 10
Simultaneous proteome localization and turnover analysis reveals spatiotemporal features of protein homeostasis disruptions
Jordan Currie, Vyshnavi Manda, Sean K Robinson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Targeting EGFR‐mediated autophagy as a potential strategy for cancer therapy
Mopa A. Sooro, Ni Zhang, Pinghu Zhang
International Journal of Cancer (2018) Vol. 143, Iss. 9, pp. 2116-2125
Open Access | Times Cited: 75
Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
Yoojung Kwon, Mi-Sun Kim, Hyun Suk Jung, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1374-1374
Open Access | Times Cited: 72
NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR
Shangce Du, Ji Miao, Zhouting Zhu, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 10
Open Access | Times Cited: 69
LAPTM4B: an oncogene in various solid tumors and its functions
Meng Zhang, Lianzhou Wang, Dongmei Chen, et al.
Oncogene (2016) Vol. 35, Iss. 50, pp. 6359-6365
Open Access | Times Cited: 68
Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer
Evangelos Koustas, Michalis V. Karamouzis, Chrysovalantou Mihailidou, et al.
Cancer Letters (2017) Vol. 396, pp. 94-102
Closed Access | Times Cited: 65
Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation
Tomohiro Tanaka, Yue Zhou, Tatsuhiko Ozawa, et al.
Journal of Biological Chemistry (2017) Vol. 293, Iss. 7, pp. 2288-2301
Open Access | Times Cited: 63
Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers
Nina Raulf, Philippe Lucarelli, Selvam Thavaraj, et al.
European Journal of Cancer (2018) Vol. 102, pp. 52-68
Open Access | Times Cited: 59
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network
Masashi Iwamoto, Wakana Saso, Kazane Nishioka, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 3, pp. 800-807
Open Access | Times Cited: 53
Binding Features and Functions of ATG3
Dongmei Fang, Huazhong Xie, Tao Hu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 41
FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth
Mengmeng Niu, Jing Xu, Yang Liu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 41
The roles of glycolysis in osteosarcoma
Zuxi Feng, Yanghuan Ou, Liang Hao
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
Milan Teraiya, Hélène Perreault, Vincent Chen
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase
Yang Wang, Yanyan Chen, Gui‐Bin Gao, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 2169-2187
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top